Strain differences in cuprizone induced demyelination
Abstract Background Multiple sclerosis (MS) is a severe neurological disorder, characterized by demyelination of the central nervous system (CNS), and with a prevalence of greater than 2 million people worldwide. In terms of research in MS pathology, the cuprizone toxicity model is widely used. Here...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Cell & Bioscience |
Online Access: | http://link.springer.com/article/10.1186/s13578-017-0181-3 |
id |
doaj-81ebbae3e9f446b899be37230a7431e0 |
---|---|
record_format |
Article |
spelling |
doaj-81ebbae3e9f446b899be37230a7431e02020-11-25T00:31:03ZengBMCCell & Bioscience2045-37012017-11-017111110.1186/s13578-017-0181-3Strain differences in cuprizone induced demyelinationQili Yu0Ryan Hui1Jiyoung Park2Yangyang Huang3Alexander W. Kusnecov4Cheryl F. Dreyfus5Renping Zhou6Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers UniversityDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers UniversityDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers UniversityDepartment of Neuroscience and Cell Biology, Rutgers Robert Wood Johnson Medical SchoolDepartment of Psychology, School of Arts and Sciences, Rutgers UniversityDepartment of Neuroscience and Cell Biology, Rutgers Robert Wood Johnson Medical SchoolDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers UniversityAbstract Background Multiple sclerosis (MS) is a severe neurological disorder, characterized by demyelination of the central nervous system (CNS), and with a prevalence of greater than 2 million people worldwide. In terms of research in MS pathology, the cuprizone toxicity model is widely used. Here we investigated the contribution of genetic differences in response to cuprizone-induced demyelination in two genetically different mouse strains: CD1 and C57BL/6. Results We demonstrate that exposure to a diet containing 0.2% cuprizone resulted in less severe demyelination in the midline of the corpus callosum over the fornix in CD1 mice than C57BL/6 mice. With continuous cuprizone feeding, demyelination in CD1 mice was not prominent until after 7 weeks, in contrast to C57BL/6 mice, which showed prominent demyelination after 4 weeks of exposure. Concomitantly, immunohistochemical analysis demonstrated more oligodendrocytes, as well as fewer oligodendrocyte progenitor cells, microglia and astrocytes in cuprizone treated CD1 mice. We also analyzed 4-weeks-cuprizone treated corpus callosum tissue samples and found that cuprizone treated CD1 mice showed a smaller reduction of myelin-associated glycoprotein (MAG) and a smaller increase of Iba1 and NG2. Conclusions These observations suggest that CD1 mice are less vulnerable to cuprizone-induced demyelination than C57BL/6 mice and thus genetic background factors appear to influence the susceptibility to cuprizone-induced demyelination.http://link.springer.com/article/10.1186/s13578-017-0181-3 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Qili Yu Ryan Hui Jiyoung Park Yangyang Huang Alexander W. Kusnecov Cheryl F. Dreyfus Renping Zhou |
spellingShingle |
Qili Yu Ryan Hui Jiyoung Park Yangyang Huang Alexander W. Kusnecov Cheryl F. Dreyfus Renping Zhou Strain differences in cuprizone induced demyelination Cell & Bioscience |
author_facet |
Qili Yu Ryan Hui Jiyoung Park Yangyang Huang Alexander W. Kusnecov Cheryl F. Dreyfus Renping Zhou |
author_sort |
Qili Yu |
title |
Strain differences in cuprizone induced demyelination |
title_short |
Strain differences in cuprizone induced demyelination |
title_full |
Strain differences in cuprizone induced demyelination |
title_fullStr |
Strain differences in cuprizone induced demyelination |
title_full_unstemmed |
Strain differences in cuprizone induced demyelination |
title_sort |
strain differences in cuprizone induced demyelination |
publisher |
BMC |
series |
Cell & Bioscience |
issn |
2045-3701 |
publishDate |
2017-11-01 |
description |
Abstract Background Multiple sclerosis (MS) is a severe neurological disorder, characterized by demyelination of the central nervous system (CNS), and with a prevalence of greater than 2 million people worldwide. In terms of research in MS pathology, the cuprizone toxicity model is widely used. Here we investigated the contribution of genetic differences in response to cuprizone-induced demyelination in two genetically different mouse strains: CD1 and C57BL/6. Results We demonstrate that exposure to a diet containing 0.2% cuprizone resulted in less severe demyelination in the midline of the corpus callosum over the fornix in CD1 mice than C57BL/6 mice. With continuous cuprizone feeding, demyelination in CD1 mice was not prominent until after 7 weeks, in contrast to C57BL/6 mice, which showed prominent demyelination after 4 weeks of exposure. Concomitantly, immunohistochemical analysis demonstrated more oligodendrocytes, as well as fewer oligodendrocyte progenitor cells, microglia and astrocytes in cuprizone treated CD1 mice. We also analyzed 4-weeks-cuprizone treated corpus callosum tissue samples and found that cuprizone treated CD1 mice showed a smaller reduction of myelin-associated glycoprotein (MAG) and a smaller increase of Iba1 and NG2. Conclusions These observations suggest that CD1 mice are less vulnerable to cuprizone-induced demyelination than C57BL/6 mice and thus genetic background factors appear to influence the susceptibility to cuprizone-induced demyelination. |
url |
http://link.springer.com/article/10.1186/s13578-017-0181-3 |
work_keys_str_mv |
AT qiliyu straindifferencesincuprizoneinduceddemyelination AT ryanhui straindifferencesincuprizoneinduceddemyelination AT jiyoungpark straindifferencesincuprizoneinduceddemyelination AT yangyanghuang straindifferencesincuprizoneinduceddemyelination AT alexanderwkusnecov straindifferencesincuprizoneinduceddemyelination AT cherylfdreyfus straindifferencesincuprizoneinduceddemyelination AT renpingzhou straindifferencesincuprizoneinduceddemyelination |
_version_ |
1725324059461287936 |